Astellas Pharma (ALPMY) Q2 2017 Earnings

27AprConfirmed
Q3 2016
Q4 2016
Q1 2017
Q2 2017
0.1
0.17
0.24
0.31

Details

Expected EPS
0.10131821658343455
Actual EPS
0.1737526431817159
Surprise EPS
0.07
Surprise Percent
+71.49%

Description

Astellas Pharma (ALPMY) has reported earnings of 0.1737526431817159 per share for Q2 2017.

0 Comments

Share your thoughts